{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:51:16Z","timestamp":1794246676277,"version":"4.9.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"United Kingdom Research and Innovation Future Leader Fellowship","id":[{"id":"https:\/\/ror.org\/001aqnf71","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Daphne Merrills PhD studentship funded jointly by Brain Research UK and Neurosciences Foundation.","id":[{"id":"https:\/\/ror.org\/01fy9e204","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,4,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Glioblastoma (GBM) is an aggressive brain tumour with a poor prognosis despite existing multimodal treatments, limited by the blood-brain barrier (BBB) and high recurrence rates. Focused ultrasound (FUS), encompassing low-intensity (LIFU) and high-intensity (HIFU) modalities, offers non-invasive approaches to enhance drug delivery and ablate tumour tissue, respectively. To systematically evaluate the efficacy and safety of LIFU-mediated BBB opening and HIFU-induced thermal ablation in GBM treatment, comparing preclinical and clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This review searched PubMed, Scopus, and Web of Science (August 2024) for studies on FUS in GBM. Preclinical and clinical studies reporting efficacy (tumour response, survival) and safety outcomes were included. Data were extracted using a standardised form, with quality assessed via SYRCLE (preclinical) and ROBINS-I (clinical) tools. Narrative synthesis was performed due to study heterogeneity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      From 1817 records, 40 studies (26 preclinical, 14 clinical with 139 patients) were included. LIFU enhanced delivery of chemotherapies, immunotherapies, and nanoparticles, reducing tumour growth and extending survival in preclinical models (e.g., 26\u201381.2 days vs. 18\u201330.4 days), with clinical trials showing progression-free survival of 2.5\u20134.11 months, overall survival of 10\u201314 months, and 100% one-year survival with temozolomide in a small cohort (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20096). HIFU achieved ~70% tumour growth inhibition preclinically but only ~10% ablation clinically. Both modalities were safe, with no severe adverse events, only mild, transient effects like petechiae (LIFU) and warmth (HIFU).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>LIFU and HIFU are promising, complementary GBM treatments, with LIFU excelling in drug delivery and HIFU in ablation. Large-scale, multicentre randomised controlled trials with standardised parameters are needed to validate their efficacy and safety and optimise their integration into clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration<\/jats:title>\n                    <jats:p>CRD42024627213.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41416-025-03325-6","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T09:11:53Z","timestamp":1767863513000},"page":"977-995","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Efficacy and safety of low- and high-intensity focused ultrasound in glioblastoma: a systematic review of preclinical and clinical studies"],"prefix":"10.1038","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0405-7155","authenticated-orcid":false,"given":"Muteb","family":"Alrashidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Febe","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas","family":"Almohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawal Hamed","family":"Alyoubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada Saleem","family":"Alsarheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6270-2559","authenticated-orcid":false,"given":"James","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2043-2989","authenticated-orcid":false,"given":"Sourav","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"3325_CR1","doi-asserted-by":"crossref","unstructured":"Grochans S, Cybulska AM, Simi\u0144ska D, Korbecki J, Kojder K, Chlubek D, et al. Epidemiology of glioblastoma multiforme-literature review. Cancers. 2022;14:2412.","DOI":"10.3390\/cancers14102412"},{"key":"3325_CR2","doi-asserted-by":"publisher","first-page":"e000144","DOI":"10.1136\/esmoopen-2016-000144","volume":"1","author":"DS N\u00f8r\u00f8xe","year":"2016","unstructured":"N\u00f8r\u00f8xe DS, Poulsen HS, Lassen U. Hallmarks of glioblastoma: a systematic review. ESMO Open. 2016;1:e000144.","journal-title":"ESMO Open"},{"key":"3325_CR3","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","volume":"25","author":"QT Ostrom","year":"2023","unstructured":"Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016\u20142020. Neuro-Oncology. 2023;25:iv1\u2013iv99.","journal-title":"Neuro-Oncology"},{"key":"3325_CR4","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","volume":"178","author":"C Neftel","year":"2019","unstructured":"Neftel C, Laffy J, Filbin MG, Hara T, Shore ME, Rahme GJ, et al. An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell. 2019;178:835\u2013849.e821.","journal-title":"Cell"},{"key":"3325_CR5","first-page":"360","volume":"38","author":"RD Read","year":"2024","unstructured":"Read RD, Tapp ZM, Rajappa P, Hambardzumyan D. Glioblastoma microenvironment-from biology to therapy. Genes Dev. 2024;38:360\u201379.","journal-title":"Genes Dev"},{"key":"3325_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13045-024-01544-7","volume":"17","author":"H Lin","year":"2024","unstructured":"Lin H, Liu C, Hu A, Zhang D, Yang H, Mao Y. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives. J Hematol Oncol. 2024;17:31.","journal-title":"J Hematol Oncol"},{"key":"3325_CR7","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1007\/s10439-021-02833-9","volume":"49","author":"VS Bachu","year":"2021","unstructured":"Bachu VS, Kedda J, Suk I, Green JJ, Tyler B. High-intensity focused ultrasound: a review of mechanisms and clinical applications. Ann Biomed Eng. 2021;49:1975\u201391.","journal-title":"Ann Biomed Eng"},{"key":"3325_CR8","doi-asserted-by":"publisher","first-page":"903059","DOI":"10.3389\/fonc.2022.903059","volume":"12","author":"R Mungur","year":"2022","unstructured":"Mungur R, Zheng J, Wang B, Chen X, Zhan R, Tong Y. Low-intensity focused ultrasound technique in glioblastoma multiforme treatment. Front Oncol. 2022;12:903059.","journal-title":"Front Oncol"},{"key":"3325_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5306\/wjco.v2.i1.8","volume":"2","author":"YF Zhou","year":"2011","unstructured":"Zhou YF. High-intensity focused ultrasound in clinical tumor ablation. World J Clin Oncol. 2011;2:8\u201327.","journal-title":"World J Clin Oncol"},{"key":"3325_CR10","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3390\/pharmaceutics13071084","volume":"13","author":"K-T Chen","year":"2021","unstructured":"Chen K-T, Wei K-C, Liu H-L. Focused ultrasound combined with microbubbles in central nervous system applications. Pharmaceutics. 2021;13:1084.","journal-title":"Pharmaceutics"},{"key":"3325_CR11","doi-asserted-by":"crossref","unstructured":"Gandhi K, Barzegar-Fallah A, Banstola A, Rizwan SB, Reynolds JNJ. Ultrasound-mediated blood-brain barrier disruption for drug delivery: a systematic review of protocols, efficacy, and safety outcomes from preclinical and clinical studies. Pharmaceutics. 2022;14:833.","DOI":"10.3390\/pharmaceutics14040833"},{"key":"3325_CR12","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1177\/0271678X17753514","volume":"39","author":"HA Kamimura","year":"2019","unstructured":"Kamimura HA, Flament J, Valette J, Cafarelli A, Aron Badin R, Hantraye P, et al. Feedback control of microbubble cavitation for ultrasound-mediated blood-brain barrier disruption in non-human primates under magnetic resonance guidance. J Cereb Blood Flow Metab. 2019;39:1191\u2013203.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3325_CR13","doi-asserted-by":"publisher","first-page":"e00352","DOI":"10.1016\/j.neurot.2024.e00352","volume":"21","author":"PG Durham","year":"2024","unstructured":"Durham PG, Butnariu A, Alghorazi R, Pinton G, Krishna V, Dayton PA. Current clinical investigations of focused ultrasound blood-brain barrier disruption: a review. Neurotherapeutics. 2024;21:e00352.","journal-title":"Neurotherapeutics"},{"key":"3325_CR14","doi-asserted-by":"publisher","first-page":"e230074","DOI":"10.1148\/rycan.230074","volume":"6","author":"A De Maio","year":"2024","unstructured":"De Maio A, Alfieri G, Mattone M, Ghanouni P, Napoli A. High-intensity focused ultrasound surgery for tumor ablation: a review of current applications. Radio Imaging Cancer. 2024;6:e230074.","journal-title":"Radio Imaging Cancer"},{"key":"3325_CR15","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.3390\/diagnostics13152595","volume":"13","author":"D Zulkifli","year":"2023","unstructured":"Zulkifli D, Manan HA, Yahya N, Hamid HA. The applications of High-Intensity Focused Ultrasound (HIFU) ablative therapy in the treatment of primary breast cancer: a systematic review. Diagn. 2023;13:2595.","journal-title":"Diagn"},{"key":"3325_CR16","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","DOI":"10.1136\/bmj.n71"},{"key":"3325_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RBM, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14:43.","journal-title":"BMC Med Res Methodol"},{"key":"3325_CR18","doi-asserted-by":"crossref","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.","DOI":"10.1136\/bmj.i4919"},{"key":"3325_CR19","doi-asserted-by":"crossref","unstructured":"McGuinness LA, Higgins JPT. Risk-of-bias Visualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synthesis Methods. 2021;12:55\u201361.","DOI":"10.1002\/jrsm.1411"},{"key":"3325_CR20","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jconrel.2024.06.036","volume":"372","author":"N McDannold","year":"2024","unstructured":"McDannold N, Wen PY, Reardon DA, Fletcher SM, Golby AJ. Cavitation monitoring, treatment strategy, and acoustic simulations of focused ultrasound blood-brain barrier disruption in patients with glioblastoma. J Control Release. 2024;372:194\u2013208.","journal-title":"J Control Release"},{"key":"3325_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-55442-6","volume":"14","author":"SP Fletcher","year":"2024","unstructured":"Fletcher SP, Chisholm A, Lavelle M, Guthier R, Zhang Y, Power C, et al. A study combining microbubble-mediated focused ultrasound and radiation therapy in the healthy rat brain and a F98 glioma model. Sci Rep. 2024;14:4831.","journal-title":"Sci Rep"},{"key":"3325_CR22","doi-asserted-by":"crossref","unstructured":"Carpentier A, Stupp R, Sonabend AM, Dufour H, Chinot O, Mathon B, et al. Repeated blood-brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I\/II clinical trial. Nat Commun. 2024;15:1650.","DOI":"10.1038\/s41467-024-45818-7"},{"key":"3325_CR23","doi-asserted-by":"crossref","unstructured":"Bhoopathi P, Mannangatti P, Pradhan AK, Kumar, A, Maji S, Lang FF, et al. Noninvasive therapy of brain cancer using a unique systemic delivery methodology with a cancer terminator virus. J Cell Physiol. 2024;239:e31302.","DOI":"10.1002\/jcp.31302"},{"key":"3325_CR24","doi-asserted-by":"crossref","unstructured":"Arrieta VA, Gould A, Kim, KS, Habashy, KJ, Dmello C, Vazquez-Cervantes GI, et al. Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomas. Nat Commun. 2024;15:4698.","DOI":"10.1038\/s41467-024-48326-w"},{"key":"3325_CR25","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.ultrasmedbio.2022.12.006","volume":"49","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Wang J, Ghobadi SN, Zhou H, Huang A, Gerosa M, et al. Molecular identity changes of tumor-associated macrophages and microglia after magnetic resonance imaging-guided focused ultrasound-induced blood-brain barrier opening in a mouse glioblastoma model. Ultrasound Med Biol. 2023;49:1082\u201390.","journal-title":"Ultrasound Med Biol"},{"key":"3325_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10408","volume":"8","author":"T Sun","year":"2023","unstructured":"Sun T, Krishnan V, Pan DC, Filippov SK, Ravid S, Sarode A, et al. Ultrasound-mediated delivery of flexibility-tunable polymer drug conjugates for treating glioblastoma. Bioeng Transl Med. 2023;8:e10408.","journal-title":"Bioeng Transl Med"},{"key":"3325_CR27","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S1470-2045(23)00112-2","volume":"24","author":"AM Sonabend","year":"2023","unstructured":"Sonabend AM, Gould A, Amidei C, Ward R, Schmidt KA, Zhang DY, et al. Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial. Lancet Oncol. 2023;24:509\u201322.","journal-title":"Lancet Oncol"},{"key":"3325_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ejpb.2022.12.006","volume":"182","author":"E Porret","year":"2023","unstructured":"Porret E, Kereselidze D, Dauba A, Schweitzer-Chaput A, Jegot B, Selingue E, et al. Refining the delivery and therapeutic efficacy of cetuximab using focused ultrasound in a mouse model of glioblastoma: an (89)Zr-cetuximab immunoPET study. Eur J Pharm Biopharm. 2023;182:141\u201351.","journal-title":"Eur J Pharm Biopharm"},{"key":"3325_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-02074-z","volume":"21","author":"C He","year":"2023","unstructured":"He C, Wu Z, Zhuang M, Li X, Xue S, Xu S, et al. Focused ultrasound-mediated blood-brain barrier opening combined with magnetic targeting cytomembrane-based biomimetic microbubbles for glioblastoma therapy. J Nanobiotechnol. 2023;21:297.","journal-title":"J Nanobiotechnol"},{"key":"3325_CR30","doi-asserted-by":"publisher","first-page":"5584","DOI":"10.7150\/thno.87168","volume":"13","author":"C Chevaleyre","year":"2023","unstructured":"Chevaleyre C, Novell A, Tournier N, Dauba A, Dubois S, Kereselidze D, et al. Efficient PD-L1 imaging of murine glioblastoma with FUS-aided immunoPET by leveraging FcRn-antibody interaction. Theranostics. 2023;13:5584\u201396.","journal-title":"Theranostics"},{"key":"3325_CR31","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s11060-023-04517-x","volume":"165","author":"KT Chen","year":"2023","unstructured":"Chen KT, Huang CY, Pai PC, Yang WC, Tseng CK, Tsai HC, et al. Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study. J Neurooncol. 2023;165:535\u201345.","journal-title":"J Neurooncol"},{"key":"3325_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.add2288","volume":"8","author":"H Lee","year":"2022","unstructured":"Lee H, Guo Y, Ross JL, Schoen S Jr., Degertekin FL, Arvanitis C. Spatially targeted brain cancer immunotherapy with closed-loop controlled focused ultrasound and immune checkpoint blockade. Sci Adv. 2022;8:eadd2288.","journal-title":"Sci Adv"},{"key":"3325_CR33","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2147\/IJN.S286221","volume":"16","author":"Q Yang","year":"2021","unstructured":"Yang Q, Zhou Y, Chen J, Huang N, Wang Z, Cheng Y. Gene therapy for drug-resistant glioblastoma via lipid-polymer hybrid nanoparticles combined with focused ultrasound. Int J Nanomed. 2021;16:185\u201399.","journal-title":"Int J Nanomed"},{"key":"3325_CR34","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ijrobp.2020.12.019","volume":"110","author":"HJ Wei","year":"2021","unstructured":"Wei HJ, Upadhyayula PS, Pouliopoulos AN, Englander ZK, Zhang X, Jan CI, et al. Focused ultrasound-mediated blood-brain barrier opening increases delivery and efficacy of etoposide for glioblastoma treatment. Int J Radiat Oncol Biol Phys. 2021;110:539\u201350.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3325_CR35","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1158\/1078-0432.CCR-20-3760","volume":"27","author":"A Sabbagh","year":"2021","unstructured":"Sabbagh A, Beccaria K, Ling XY, Marisetty A, Ott M, Caruso H, et al. Opening of the blood-brain barrier using low-intensity pulsed ultrasound enhances responses to immunotherapy in preclinical glioma models. Clin Cancer Res. 2021;27:4325\u201337.","journal-title":"Clin Cancer Res"},{"key":"3325_CR36","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3171\/2019.10.JNS192206","volume":"134","author":"SH Park","year":"2021","unstructured":"Park SH, Kim MJ, Jung HH, Chang WS, Choi HS, Rachmilevitch I, et al. Safety and feasibility of multiple blood-brain barrier disruptions for the treatment of glioblastoma in patients undergoing standard adjuvant chemotherapy. J Neurosurg. 2021;134:475\u201383.","journal-title":"J Neurosurg"},{"key":"3325_CR37","doi-asserted-by":"crossref","unstructured":"Molotkov A, Carberry P, Dolan MA, Joseph S, Idumonyi S, Oya S, et al. Real-time positron emission tomography evaluation of topotecan brain kinetics after ultrasound-mediated blood-brain barrier permeability. Pharmaceutics. 2021;13:405.","DOI":"10.3390\/pharmaceutics13030405"},{"key":"3325_CR38","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1093\/neuonc\/noab057","volume":"23","author":"Y Meng","year":"2021","unstructured":"Meng Y, Pople CB, Suppiah S, Llinas M, Huang YX, Sahgal A, et al. MR-guided focused ultrasound liquid biopsy enriches circulating biomarkers in patients with brain tumors. Neuro-Oncology. 2021;23:1789\u201397.","journal-title":"Neuro-Oncology"},{"key":"3325_CR39","doi-asserted-by":"publisher","first-page":"711088","DOI":"10.3389\/fonc.2021.711088","volume":"11","author":"WH Liao","year":"2021","unstructured":"Liao WH, Hsiao MY, Kung Y, Huang AP, Chen WS. Investigation of the therapeutic effect of doxorubicin combined with focused shockwave on glioblastoma. Front Oncol. 2021;11:711088.","journal-title":"Front Oncol"},{"key":"3325_CR40","doi-asserted-by":"crossref","unstructured":"Chen KT, Chai WY, Lin, YJ, Lin, CJ, Chen, PY, Tsai HC, et al. Neuronavigation-guided focused ultrasound for transcranial blood-brain barrier opening and immunostimulation in brain tumors. Sci Adv. 2021;7:eabd0772.","DOI":"10.1126\/sciadv.abd0772"},{"key":"3325_CR41","doi-asserted-by":"publisher","first-page":"26759","DOI":"10.1021\/acsami.1c04990","volume":"13","author":"MH Chan","year":"2021","unstructured":"Chan MH, Chen W, Li CH, Fang CY, Chang YC, Wei DH, et al. An advanced in situ magnetic resonance imaging and ultrasonic theranostics nanocomposite platform: crossing the blood-brain barrier and improving the suppression of glioblastoma using iron-platinum nanoparticles in nanobubbles. ACS Appl Mater Interfaces. 2021;13:26759\u201369.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3325_CR42","doi-asserted-by":"crossref","unstructured":"Wang S, Wu CC, Zhang H, Karakatsani ME, Wang YF, Han Y, et al. Focused ultrasound induced-blood- brain barrier opening in mouse brain receiving radiosurgery dose of radiation enhances local delivery of systemic therapy. Br J Radiol. 2020;93:20190214.","DOI":"10.1259\/bjr.20190214"},{"key":"3325_CR43","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.3389\/fonc.2020.01663","volume":"10","author":"SH Park","year":"2020","unstructured":"Park SH, Kim MJ, Jung HH, Chang WS, Choi HS, Rachmilevitch I, et al. One-year outcome of multiple blood-brain barrier disruptions with temozolomide for the treatment of glioblastoma. Front Oncol. 2020;10:1663.","journal-title":"Front Oncol"},{"key":"3325_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-65617-6","volume":"10","author":"N McDannold","year":"2020","unstructured":"McDannold N, Zhang Y, Supko JG, Power C, Sun T, Vykhodtseva N, et al. Blood-brain barrier disruption and delivery of irinotecan in a rat model using a clinical transcranial MRI-guided focused ultrasound system. Sci Rep. 2020;10:8766.","journal-title":"Sci Rep"},{"key":"3325_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aay1344","volume":"6","author":"CT Curley","year":"2020","unstructured":"Curley CT, Mead BP, Negron K, Kim N, Garrison WJ, Miller GW, et al. Augmentation of brain tumor interstitial flow via focused ultrasound promotes brain-penetrating nanoparticle dispersion and transfection. Sci Adv. 2020;6:eaay1344.","journal-title":"Sci Adv"},{"key":"3325_CR46","volume":"2","author":"C Brighi","year":"2020","unstructured":"Brighi C, Reid L, White AL, Genovesi LA, Kojic M, Millar A, et al. MR-guided focused ultrasound increases antibody delivery to nonenhancing high-grade glioma. Neurooncol Adv. 2020;2:vdaa030.","journal-title":"Neurooncol Adv"},{"key":"3325_CR47","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.ultrasmedbio.2018.10.016","volume":"45","author":"M Yoshida","year":"2019","unstructured":"Yoshida M, Kobayashi H, Terasaka S, Endo S, Yamaguchi S, Motegi H, et al. Sonodynamic therapy for malignant glioma using 220-kHz transcranial magnetic resonance imaging-guided focused ultrasound and 5-aminolevulinic acid. Ultrasound Med Biol. 2019;45:526\u201338.","journal-title":"Ultrasound Med Biol"},{"key":"3325_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46832-2","volume":"9","author":"SK Wu","year":"2019","unstructured":"Wu SK, Santos MA, Marcus SL, Hynynen K. MR-guided focused ultrasound facilitates sonodynamic therapy with 5-aminolevulinic acid in a rat glioma model. Sci Rep. 2019;9:10465.","journal-title":"Sci Rep"},{"key":"3325_CR49","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10439-018-02141-9","volume":"47","author":"Z Pi","year":"2019","unstructured":"Pi Z, Huang Y, Shen Y, Zeng X, Hu Y, Chen T, et al. Sonodynamic therapy on intracranial glioblastoma xenografts using sinoporphyrin sodium delivered by ultrasound with microbubbles. Ann Biomed Eng. 2019;47:549\u201362.","journal-title":"Ann Biomed Eng"},{"key":"3325_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-36340-0","volume":"9","author":"T Mainprize","year":"2019","unstructured":"Mainprize T, Lipsman N, Huang Y, Meng Y, Bethune A, Ironside S, et al. Blood-brain barrier opening in primary brain tumors with non-invasive MR-guided focused ultrasound: a clinical safety and feasibility study. Sci Rep. 2019;9:321.","journal-title":"Sci Rep"},{"key":"3325_CR51","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1158\/1078-0432.CCR-18-3643","volume":"25","author":"A Idbaih","year":"2019","unstructured":"Idbaih A, Canney M, Belin L, Desseaux C, Vignot A, Bouchoux G, et al. Safety and feasibility of repeated and transient blood-brain barrier disruption by pulsed ultrasound in patients with recurrent glioblastoma. Clin Cancer Res. 2019;25:3793\u2013801.","journal-title":"Clin Cancer Res"},{"key":"3325_CR52","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.2147\/IJN.S193258","volume":"14","author":"SW Ha","year":"2019","unstructured":"Ha SW, Hwang K, Jin J, Cho AS, Kinn TY, Hwang SI, et al. Ultrasound-sensitizing nanoparticle complex for overcoming the blood-brain barrier: an effective drug delivery system. Int J Nanomed. 2019;14:3743\u201352.","journal-title":"Int J Nanomed"},{"key":"3325_CR53","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jconrel.2016.10.011","volume":"250","author":"J Park","year":"2017","unstructured":"Park J, Aryal M, Vykhodtseva N, Zhang YZ, McDannold N. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption. J Control Release. 2017;250:77\u201385.","journal-title":"J Control Release"},{"key":"3325_CR54","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00280-015-2926-1","volume":"77","author":"Q Lin","year":"2016","unstructured":"Lin Q, Mao KL, Tian FR, Yang JJ, Chen PP, Xu J, et al. Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes. Cancer Chemother Pharmacol. 2016;77:269\u201380.","journal-title":"Cancer Chemother Pharmacol"},{"key":"3325_CR55","doi-asserted-by":"crossref","unstructured":"Carpentier A, Canney M, Vignot A, Reina V, Beccaria K, Horodyckid C, et al. Clinical trial of blood-brain barrier disruption by pulsed ultrasound. Sci Transl Med. 2016;8:343re2.","DOI":"10.1126\/scitranslmed.aaf6086"},{"key":"3325_CR56","doi-asserted-by":"publisher","first-page":"36260","DOI":"10.18632\/oncotarget.5389","volume":"6","author":"FY Yang","year":"2015","unstructured":"Yang FY, Chang WY, Lin WT, Hwang JJ, Chien YC, Wang HE, et al. Focused ultrasound enhanced molecular imaging and gene therapy for multifusion reporter gene in glioma-bearing rat model. Oncotarget. 2015;6:36260\u20138.","journal-title":"Oncotarget"},{"key":"3325_CR57","doi-asserted-by":"crossref","unstructured":"Chen PY, Hsieh, HY, Huang, CY, Lin, CY, Wei, KC & Liu, HL Focused ultrasound-induced blood-brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy: a preclinical feasibility study. J Transl Med. 2015;13:93.","DOI":"10.1186\/s12967-015-0451-y"},{"key":"3325_CR58","doi-asserted-by":"crossref","unstructured":"Coluccia D, Fandino J, Schwyzer L, O\u2019Gorman R, Remonda L, Anon J et al. First noninvasive thermal ablation of a brain tumor with MR-guided focused ultrasound. J Ther Ultrasound. 2014;2:17.","DOI":"10.1186\/2050-5736-2-17"},{"key":"3325_CR59","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1227\/01.NEU.0000360379.95800.2F","volume":"66","author":"N McDannold","year":"2010","unstructured":"McDannold N, Clement GT, Black P, Jolesz F, Hynynen K. Transcranial magnetic resonance imaging-guided focused ultrasound surgery of brain tumors: initial findings in 3 patients. Neurosurgery. 2010;66:323\u201332.","journal-title":"Neurosurgery"},{"key":"3325_CR60","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s44222-023-00030-y","volume":"1","author":"J Deckers","year":"2023","unstructured":"Deckers J, Anbergen T, Hokke AM, de Dreu A, Schrijver DP, de Bruin K, et al. Engineering cytokine therapeutics. Nat Rev Bioeng. 2023;1:286\u2013303.","journal-title":"Nat Rev Bioeng"},{"key":"3325_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28523-1","volume":"13","author":"VM Ravi","year":"2022","unstructured":"Ravi VM, Neidert N, Will P, Joseph K, Maier JP, K\u00fcckelhaus J, et al. T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10. Nat Commun. 2022;13:925.","journal-title":"Nat Commun"},{"key":"3325_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155144","volume":"254","author":"G Broggi","year":"2024","unstructured":"Broggi G, Angelico G, Farina J, Tinnirello G, Barresi V, Zanelli M, et al. Tumor-associated microenvironment, PD-L1 expression and their relationship with immunotherapy in glioblastoma, IDH-wild type: a comprehensive review with emphasis on the implications for neuropathologists. Pathol Res Pract. 2024;254:155144.","journal-title":"Pathol Res Pract"},{"key":"3325_CR63","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3389\/fonc.2020.01015","volume":"10","author":"C Hao","year":"2020","unstructured":"Hao C, Chen G, Zhao H, Li Y, Chen J, Zhang H, et al. PD-L1 Expression in glioblastoma, the clinical and prognostic significance: a systematic literature review and meta-analysis. Front Oncol. 2020;10:1015.","journal-title":"Front Oncol"},{"key":"3325_CR64","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1158\/2159-8290.CD-23-0913","volume":"14","author":"AZ Wang","year":"2024","unstructured":"Wang AZ, Mashimo BL, Schaettler MO, Sherpa ND, Leavitt LA, Livingstone AJ, et al. Glioblastoma-infiltrating CD8+ T cells are predominantly a clonally expanded GZMK+ effector population. Cancer Discov. 2024;14:1106\u201331.","journal-title":"Cancer Discov"},{"key":"3325_CR65","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/jnr.25134","volume":"101","author":"M Giambra","year":"2023","unstructured":"Giambra M, Di Cristofori A, Valtorta S, Manfrellotti R, Bigiogera V, Basso G, et al. The peritumoral brain zone in glioblastoma: where we are and where we are going. J Neurosci Res. 2023;101:199\u2013216.","journal-title":"J Neurosci Res"},{"key":"3325_CR66","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1089\/ars.2022.0187","volume":"39","author":"R Srivastava","year":"2023","unstructured":"Srivastava R, Dodda M, Zou H, Li X, Hu B. Tumor niches: perspectives for targeted therapies in glioblastoma. Antioxid Redox Signal. 2023;39:904\u201322.","journal-title":"Antioxid Redox Signal"},{"key":"3325_CR67","doi-asserted-by":"crossref","unstructured":"Arrieta VA, Dmello C, McGrail DJ, Brat DJ, Lee-Chang C, Heimberger AB, et al. Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment. J Clin Invest. 2023;133:e163447.","DOI":"10.1172\/JCI163447"},{"key":"3325_CR68","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00401-007-0293-7","volume":"114","author":"A Claes","year":"2007","unstructured":"Claes A, Idema AJ, Wesseling P. Diffuse glioma growth: a guerilla war. Acta Neuropathol. 2007;114:443\u201358.","journal-title":"Acta Neuropathol"},{"key":"3325_CR69","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/CCO.0000000000000990","volume":"35","author":"MH Ahmed","year":"2023","unstructured":"Ahmed MH, Canney M, Carpentier A, Thanou M, Idbaih A. Unveiling the enigma of the blood-brain barrier in glioblastoma: current advances from preclinical and clinical studies. Curr Opin Oncol. 2023;35:522\u20138.","journal-title":"Curr Opin Oncol"},{"key":"3325_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-47562-2","volume":"13","author":"A Keenlyside","year":"2023","unstructured":"Keenlyside A, Marples T, Gao Z, Hu H, Nicely LG, Nogales J, et al. Development and optimisation of in vitro sonodynamic therapy for glioblastoma. Sci Rep. 2023;13:20215.","journal-title":"Sci Rep"},{"key":"3325_CR71","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41416-024-02898-y","volume":"132","author":"VG Collins","year":"2025","unstructured":"Collins VG, Hutton D, Hossain-Ibrahim K, Joseph J, Banerjee S. The abscopal effects of sonodynamic therapy in cancer. Br J Cancer. 2025;132:409\u201320.","journal-title":"Br J Cancer"},{"key":"3325_CR72","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1001\/jama.2017.18718","volume":"318","author":"R Stupp","year":"2017","unstructured":"Stupp R, Taillibert S, Kanner A, Read W, Steinberg DM, Lhermitte B, et al. Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial. JAMA. 2017;318:2306\u201316.","journal-title":"JAMA"},{"key":"3325_CR73","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1148\/radiol.2016152444","volume":"281","author":"H-L Liu","year":"2016","unstructured":"Liu H-L, Hsu P-H, Lin C-Y, Huang C-W, Chai W-Y, Chu P-C, et al. Focused ultrasound enhances central nervous system delivery of bevacizumab for malignant glioma treatment. Radiology. 2016;281:99\u2013108.","journal-title":"Radiology"},{"key":"3325_CR74","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.eururo.2024.11.006","volume":"87","author":"G Ploussard","year":"2025","unstructured":"Ploussard G, Coloby P, Chevallier T, Occ\u00e9an B-V, Hou\u00e9d\u00e9 N, Villers A, et al. Whole-gland or subtotal high-intensity focused ultrasound versus radical prostatectomy: the prospective, noninferiority, nonrandomized HIFI trial. Eur Urol. 2025;87:526\u201333.","journal-title":"Eur Urol"},{"key":"3325_CR75","doi-asserted-by":"publisher","first-page":"e1004408","DOI":"10.1371\/journal.pmed.1004408","volume":"21","author":"D Moore-Palhares","year":"2024","unstructured":"Moore-Palhares D, Dasgupta A, Saifuddin M, Anzola Pena ML, Prasla S, Ho L, et al. Radiation enhancement using focussed ultrasound-stimulated microbubbles for breast cancer: a phase 1 clinical trial. Plos Med. 2024;21:e1004408.","journal-title":"Plos Med"},{"key":"3325_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-40551-5","volume":"13","author":"A Dasgupta","year":"2023","unstructured":"Dasgupta A, Saifuddin M, McNabb E, Ho L, Lu L, Vesprini D, et al. Novel MRI-guided focussed ultrasound stimulated microbubble radiation enhancement treatment for breast cancer. Sci Rep. 2023;13:13566.","journal-title":"Sci Rep"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03325-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03325-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03325-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T18:24:23Z","timestamp":1773771863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03325-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":76,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,4,5]]}},"alternative-id":["3325"],"URL":"https:\/\/doi.org\/10.1038\/s41416-025-03325-6","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SB is the cofounder, shareholder and consultant of Branch Therapeutics. All other authors declare no conflicts of interest with the contents of this systematic review.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}